Providence Central Division – Power user classes are designed to increase the use of personalization settings, covering more than 150 tips and tricks.
July’s online session allows you to attend all eight classes in the Power User program in one day. Each class includes a fast-paced presentation and time for questions. This training program also comes with eight hours of CME credit – free!
Join us 8 a.m. to 5 p.m., Friday, July 14. Get details and sign-up instructions.
In 2023, Providence in Oregon did so much to make sure that essential resources – such as health care, food and shelter – were more readily available to the people of our state.
A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec
Walk in the shoes of security officer Patricia Varela and her K-9 partner Nix, and experience their important work to keep everyone safe at Providence Portland Medical Center.
Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.
This morning, six Providence hospitals in Oregon welcomed our nurses back as we began working together again.
Here's what to know about getting care at Providence hospitals during the Oregon Nurses Association strike.
June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer
Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.
The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
Practice Greenhealth recognizes Providence’s commitment to environmental stewardship, names Providence a ‘System of Change’
Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.
Jennifer Burrows, RN, has been chosen to serve as the chief executive of Providence Oregon.
Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.
In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.
In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.
In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.
Please revert to normal e-prescribing workflows and stop using paper prescriptions.
